Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pbs-Bio
AddedFeb 18, 2024
UpdatedJun 18, 2026
Pbs-Bio

Pbs-Bio

Angel

Arizona-based Predictive Biomarker Sciences develops innovative cancer treatment technologies for pharmaceutical research.

HQ
Mesa, AZ, US
Founded
2006
Overview
Compare
Fundraising
Employees

Predictive Biomarker Sciences, Inc. (Pbs-Bio) develops cancer treatment technologies aimed at enhancing pre-clinical research for pharmaceutical clients. Their core technology analyzes primary tumor cell lines' responses to investigational drugs using fluorescent reporters. Founded in 2006, the company is based in Mesa, Arizona.

Pbs-Bio has made significant strides in the field of cancer research, providing valuable insights that aid pharmaceutical companies in developing effective treatments. Their innovative approach has positioned them as a key player in the biotech industry, contributing to advancements in personalized medicine.

Pbs-Bio - Similar Companies

Predictive Biosciences logo

Predictive Biosciences

Predictive Oncology logo

Predictive Oncology

BioMarker Strategies logo

BioMarker Strategies

PredxBio logo

PredxBio

predxbio.com

NantBio logo

NantBio

Empiri logo

Empiri

empiricancer.com

Stemina Biomarker Discovery logo

Stemina Biomarker Discovery

stemina.com

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

Path BioAnalytics logo

Path BioAnalytics

BioDetego logo

BioDetego

Pediatric Bioscience logo

Pediatric Bioscience

Phoenix Biotechnology logo

Phoenix Biotechnology

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

CytoSite Biopharma logo

CytoSite Biopharma

Noble Life Sciences logo

Noble Life Sciences

noblelifesci.com

Pbs-Bio - Quick Facts

Who are Pbs-Bio's competitors?

Companies similar to Pbs-Bio include Predictive Biosciences, Predictive Oncology, BioMarker Strategies and PredxBio.

When was Pbs-Bio founded?

Pbs-Bio was founded in 2006.

Where is Pbs-Bio's headquarters located?

Pbs-Bio's headquarters is located in Mesa, AZ, US.

When was Pbs-Bio's last funding round?

Pbs-Bio's most recent funding round was for $338.1k (USD) in January 2010.

How much has Pbs-Bio raised to-date?

As of Jan 27, 2010, Pbs-Bio has raised a total of $338.1k (USD).

How many employees does Pbs-Bio have?

Pbs-Bio has 6 employees as of Feb 4, 2024.

Pbs-Bio - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Pharmaceutical Research
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified